Robert W. Lee, Ph.D., provides direction for product and business development for Particle Sciences, Inc., an Agno Pharma company (PSI). Before joining PSI, Rob held senior management positions at Novavax, Lyotropic Therapeutics, , and Imcor Pharmaceutical Co. He was one of the founding scientists at NanoSystems, built and led their Analytical Sciences Department and after NanoSystems was acquired by élan, built and was head of élan’s Sterile Products Department. He holds B.S.s in Biology and Chemistry from the University of Washington and a Ph.D. in Physical Bioorganic Chemistry from the University of California, Santa Barbara. Rob has published articles in numerous peer-reviewed journals and six book chapters plus holds over two dozen issued patents or provisional patent applications. Rob has moderated ACS and other conference sessions, served on the AAPS planning committee (Particle Size Analysis), Interphex’s Scientific Programming Advisory Committee,  and presented at AAPS workshops.